Search - tctmd.com

Displaying 141 - 160 of 194

Sort: Relevancy | Date

Presentation NY Valves 2024

Keynote Lecture: Heterotopic TTVR: Where Do We Draw the Line in Patient Indication?

Presenter: Rodrigo D. Estevez-Loureiro

June 06, 2024

Presentation NY Valves 2024

Early Feasibility Study of the Laplace TTVR System in Patients With Severe, Symptomatic Tricuspid Regurgitation

Presenter: Thomas E. Waggoner

June 06, 2024

Presentation NY Valves 2024

The Trisol Medical TTVR System: US Experience

Presenter: Vinod H. Thourani

June 06, 2024

Presentation NY Valves 2024

The Topaz TTVR System: Technology for Expanded Patient Access and EFS Update

Presenter: Hendrik Treede

June 06, 2024

Presentation NY Valves 2024

Keynote Lecture: Impact of TTVR on Hemodynamics and Ventricular Performance: Are New Generation Technologies Addressing the Physiologic Needs?

Presenter: Philipp Lurz

June 06, 2024

Presentation NY Valves 2024

Live-in-a-Box TTVR Case with Emphasis on Intraprocedural Imaging

Presenter: Raj Makkar, Moody M. Makar

June 06, 2024

Presentation NY Valves 2024

Pro-TTVR: Total TR Resolution Must be a Goal and is a Key Factor Impacting Long-Term Outcomes

Presenter: Stephan Windecker

June 05, 2024

Presentation TCT 2023

Next Generation TTVR: Overview of Devices and Current Status

Presenter: Isaac George

October 26, 2023

Presentation TCT 2023

Orthotopic TTVR: What Have We Learned From the EFS studies

Presenter: Susheel Kodali

October 26, 2023

Presentation TCT 2023

Heterotopic TTVR: Clinical Updates and Device Overviews

Presenter: Rodrigo Estevez-Loureiro

October 26, 2023

Presentation TCT 2023

Why TTVR Over TEER: Anatomic and Clinical Considerations

Presenter: Charles Davidson

October 26, 2023

Presentation TCT 2023

Anatomic Screening for TTVR: Role of CT

Presenter: Jonathon Leipsic

October 26, 2023

Presentation TCT 2023

Managing Conduction Disorders Post TTVR

Presenter: Christine Albert

October 26, 2023

Presentation TCT 2023

Leaflet Thrombosis and HALT: The Achilles Heel of TTVR?

Presenter: Rahul Sharma

October 26, 2023

Presentation TCT 2023

Who Are the TTVR Patients We Are Treating and What Are the Challenges?

Presenter: Marta Sitges

October 26, 2023

Presentation TVT 2023

When Heterotopic TTVR is the Optimal Choice: A Series of Complex Case Examples

Presenter: Rishi Puri

June 10, 2023

Presentation TVT 2023

Heterotopic TTVR Indications Are Limited, and Should Be Considered Palliative Therapy

Presenter: Scott Lim

June 10, 2023

Presentation TVT 2023

KEYNOTE LECTURE: The Concept of Heterotopic TTVR: Pathophysiologic and Anatomical Considerations; TRICUS and TRICAV Clinical Trial Updates

Presenter: Rishi Puri

June 10, 2023

Presentation TVT 2023

The Cardiovalve TTVR System: Human Clinical Experience (TARGET Trial)

Presenter: Matti Adam

June 09, 2023

Presentation TVT 2023

First in Human Transfemoral TTVR with an Innovative Valve Replacement System (Topaz)

Presenter: Geraldine Ong

June 09, 2023

Advertisement

Keynote Lecture: Heterotopic TTVR: Where Do We Draw the Line in Patient Indication?

Early Feasibility Study of the Laplace TTVR System in Patients With Severe, Symptomatic Tricuspid Regurgitation

The Trisol Medical TTVR System: US Experience

The Topaz TTVR System: Technology for Expanded Patient Access and EFS Update

Keynote Lecture: Impact of TTVR on Hemodynamics and Ventricular Performance: Are New Generation Technologies Addressing the Physiologic Needs?

Live-in-a-Box TTVR Case with Emphasis on Intraprocedural Imaging

Pro-TTVR: Total TR Resolution Must be a Goal and is a Key Factor Impacting Long-Term Outcomes

Next Generation TTVR: Overview of Devices and Current Status

Orthotopic TTVR: What Have We Learned From the EFS studies

Heterotopic TTVR: Clinical Updates and Device Overviews

Why TTVR Over TEER: Anatomic and Clinical Considerations

Anatomic Screening for TTVR: Role of CT

Managing Conduction Disorders Post TTVR

Leaflet Thrombosis and HALT: The Achilles Heel of TTVR?

Who Are the TTVR Patients We Are Treating and What Are the Challenges?

When Heterotopic TTVR is the Optimal Choice: A Series of Complex Case Examples

Heterotopic TTVR Indications Are Limited, and Should Be Considered Palliative Therapy

KEYNOTE LECTURE: The Concept of Heterotopic TTVR: Pathophysiologic and Anatomical Considerations; TRICUS and TRICAV Clinical Trial Updates

The Cardiovalve TTVR System: Human Clinical Experience (TARGET Trial)

First in Human Transfemoral TTVR with an Innovative Valve Replacement System (Topaz)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content